Skip to main content
Top
Published in: Diseases of the Colon & Rectum 11/2007

01-11-2007 | Original Contributions

Multivariate Analysis of Predictive Factors for Early Postoperative Death After Colorectal Surgery in Patients with Colorectal Cancer and Synchronous Unresectable Liver Metastases

Authors: Eric Vibert, M.D., Frederic Bretagnol, M.D., Arnaud Alves, M.D., Marc Pocard, M.D., Patrice Valleur, M.D., Yves Panis, M.D.

Published in: Diseases of the Colon & Rectum | Issue 11/2007

Login to get access

Abstract

Purpose

Surgery of the primary tumor in patients with colorectal cancer and unresectable synchronous liver metastases remains controversial. This study was designed to evaluate predictive preoperative factors of early postoperative death (<3 months) in such patients.

Methods

This study included 80 patients who underwent colorectal resection (n--6) or diversion stoma (n--4) for colorectal cancer with unresectable liver metastases. Twenty-two patients (28 percent) died during the first three months after surgery with two (2.5 percent) in-hospital postoperative deaths. Analysis of predictive preoperative factors for three-month postoperative death risk was performed.

Results

In univariate analysis, age older than 75 years (P--.01), American Society of Anesthesiologists grade > II (P--.009), symptomatic patient (P--.01), bowel obstruction (P--.03), aspartate aminotransferase serum level >50 (1.5 N) IU/L (P--.008), and alkaline phosphatase >200 (2 N) IU/L (P--.02) were prognostic risk factors for three-month death after surgery. In multivariate analysis, age older than 75 years (relative risk--.9; P--.04) and aspartate aminotransferase serum level >50 IU/L (relative risk--.3; P--.03) were independent risk factors.

Conclusions

In patients with colorectal cancer and synchronous unresectable liver metastases, the three-month mortality rate was high (28 percent). Thus, better knowledge of risk factors could help select patients who could possibly benefit from surgery. The study suggested that age older than 75 years and liver cytolysis (>1.5 N) are associated with an increased three-month postoperative death risk. In these patients, surgery should be avoided.
Literature
1.
go back to reference Faivre J, Manfredi S, Bouvier AM. Epidemiology of colorectal cancer liver metastases. Bull Acad Natl Med 2003;187:815-2.PubMed Faivre J, Manfredi S, Bouvier AM. Epidemiology of colorectal cancer liver metastases. Bull Acad Natl Med 2003;187:815-2.PubMed
2.
go back to reference Al-Sanea N, Isbister WH. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control? ANZ J Surg 2004;74:229-2.CrossRefPubMed Al-Sanea N, Isbister WH. Is palliative resection of the primary tumour, in the presence of advanced rectal cancer, a safe and useful technique for symptom control? ANZ J Surg 2004;74:229-2.CrossRefPubMed
3.
go back to reference Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722-.CrossRefPubMed Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722-.CrossRefPubMed
4.
go back to reference Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003;46:1646-2.CrossRefPubMed Kuo LJ, Leu SY, Liu MC, Jian JJ, Hongiun Cheng S, Chen CM. How aggressive should we be in patients with stage IV colorectal cancer? Dis Colon Rectum 2003;46:1646-2.CrossRefPubMed
5.
go back to reference Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-.CrossRefPubMed Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6:651-.CrossRefPubMed
6.
go back to reference Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92:1155-0.CrossRefPubMed Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92:1155-0.CrossRefPubMed
7.
go back to reference Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003;52:568-3CrossRefPubMed Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003;52:568-3CrossRefPubMed
8.
go back to reference Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004;47:1455-1CrossRefPubMed Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open operation for palliation of colorectal cancer: a retrospective, cohort study of perioperative outcome and long-term survival. Dis Colon Rectum 2004;47:1455-1CrossRefPubMed
9.
go back to reference Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-0.CrossRefPubMed Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846-0.CrossRefPubMed
10.
go back to reference Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005;89:211-.CrossRefPubMed Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005;89:211-.CrossRefPubMed
11.
go back to reference Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530-.CrossRefPubMed Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 2000;135:530-.CrossRefPubMed
12.
go back to reference Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer–is it worthwhile? Dis Colon Rectum 1997;40:11-.CrossRefPubMed Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer–is it worthwhile? Dis Colon Rectum 1997;40:11-.CrossRefPubMed
13.
go back to reference Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004;22:3475-4.CrossRefPubMed Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 2004;22:3475-4.CrossRefPubMed
14.
go back to reference Sarela A, O’Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:163-.CrossRefPubMed Sarela A, O’Riordain DS. Rectal adenocarcinoma with liver metastases: management of the primary tumour. Br J Surg 2001;88:163-.CrossRefPubMed
15.
go back to reference Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004;47:39–43.CrossRefPubMed Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004;47:39–43.CrossRefPubMed
16.
go back to reference Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321:531-CrossRefPubMed Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321:531-CrossRefPubMed
17.
go back to reference Michel P, Roque I, Di Fiore F, et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumour be resected? Gastroenterol Clin Biol 2004;28:434-.PubMedCrossRef Michel P, Roque I, Di Fiore F, et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumour be resected? Gastroenterol Clin Biol 2004;28:434-.PubMedCrossRef
Metadata
Title
Multivariate Analysis of Predictive Factors for Early Postoperative Death After Colorectal Surgery in Patients with Colorectal Cancer and Synchronous Unresectable Liver Metastases
Authors
Eric Vibert, M.D.
Frederic Bretagnol, M.D.
Arnaud Alves, M.D.
Marc Pocard, M.D.
Patrice Valleur, M.D.
Yves Panis, M.D.
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 11/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-9025-2

Other articles of this Issue 11/2007

Diseases of the Colon & Rectum 11/2007 Go to the issue

Selected Abstracts

Selected Abstracts